PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box - 17666, Al Ain, United Arab Emirates.\', \'Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box - 17666, Al Ain, United Arab Emirates.\', \'Shri Vile Parle Kelvani Mandal\'s Institute of Pharmacy, Dhule, Maharashtra, 424 001, India.\', \'Division of Hematology, Division of Nephrology, Mayo Clinic, Rochester, Minnesota, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/ddr.21752
?:hasPublicationType
?:journal
  • Drug development research
is ?:pmid of
?:pmid
?:pmid
  • 33190277
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.65
?:rankingScore_hIndex
  • 53
is ?:relation_isRelatedTo_publication of
?:title
  • CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33190277>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33190277>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all